Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 T Stamp A IDAI Mar 6, 2026 2.66 -1.85   
 T-Mobile US TMUS Mar 6, 2026 221.57 +0.47   
 T. Rowe Price Blue Chip Growth ETF TCHP Mar 6, 2026 46.30 -1.62   
 T. Rowe Price Dividend Growth ETF TDVG Mar 6, 2026 45.76 -1.12   
 T. Rowe Price Equity Income ETF TEQI Mar 6, 2026 45.88 -1.04   
 T. Rowe Price Group TROW Mar 6, 2026 90.40 -1.78   
 T. Rowe Price Growth Stock ETF TGRW Mar 6, 2026 42.73 -1.36   
 T1 Energy TE Mar 6, 2026 6.72 -1.32   
 Taboola.com TBLA Mar 6, 2026 3.30 -2.94   
 Tactile Systems Technology TCMD Mar 6, 2026 28.81 -2.04   
 Tailwind 2.0 Acquisition A TDWD Mar 6, 2026 9.93 0.00   
 Tailwind 2.0 Acquisition Unit TDWDU Mar 6, 2026 10.10 0.00   
 Taitron Components A TAIT Mar 6, 2026 1.05 0.00   
 Taiwan Fund TWN Mar 6, 2026 60.59 -0.12   
 Taiwan Index MSCI Ishares EWT Mar 6, 2026 69.52 -1.25   
 Taiwan Semiconductor Manufacturing ADR TSM Mar 6, 2026 338.89 -4.23   
 Take-Two Interactive Software TTWO Mar 6, 2026 211.50 -0.48   
 Takeda Pharmaceutical ADR TAK Mar 6, 2026 17.88 +0.68   
 TAL Education Group ADR TAL Mar 6, 2026 10.64 +2.01   
 Talen Energy TLN Mar 6, 2026 320.56 -4.27   
 Talkspace TALK Mar 6, 2026 4.76 -0.42   
 Talon Capital TLNC Mar 6, 2026 10.11 -0.10   
 Talon Capital Unit TLNCU Mar 6, 2026 10.27 0.00   
 Talos Energy TALO Mar 6, 2026 13.27 +0.23   
 Talphera TLPH Mar 6, 2026 0.87 -0.83   
 Tamboran Resources TBN Mar 6, 2026 31.00 0.00   
 Tandem Diabetes Care TNDM Mar 6, 2026 21.14 -6.58   
 Tanger SKT Mar 6, 2026 36.00 -2.01   
 Tango Therapeutics TNGX Mar 6, 2026 16.95 +0.71   
 Tantech TANH Mar 6, 2026 0.79 -1.22   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.